TerminatedPhase 1

(VELA) Study of BLU-222 in Advanced Solid Tumors

NCT05252416

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States

+22 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2022-04-07
Enrollment: 50 participants
Sponsor: Blueprint Medicines Corporation
Purpose: treatment

Locations (23)

University of Arkansas for Medical SciencesLittle Rock, Arkansas, United States
UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, California, United States
Stanford Women's Cancer CenterStanford, California, United States
Florida Cancer SpecialistsSarasota, Florida, United States
University of Chicago Medical CenterChicago, Illinois, United States
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (SKCCC)Baltimore, Maryland, United States
Massachusetts General HospitalBoston, Massachusetts, United States
Dana-Farber Cancer InstituteBoston, Massachusetts, United States
Henry Ford Health SystemDetroit, Michigan, United States
Columbia University Herbert Irving Comprehensive Cancer CenterNew York, New York, United States
Memorial Sloan Kettering Cancer CenterNew York, New York, United States
Montefiore Medical CenterNew York, New York, United States
UNC Hospitals at Chapel Hill - The University of North Carolina at Chapel HillChapel Hill, North Carolina, United States
OU Health Stephenson Cancer CenterOklahoma City, Oklahoma, United States
Hospital of the Fox Chase Cancer CenterPhiladelphia, Pennsylvania, United States
Vanderbilt Breast Center at One Hundred OaksNashville, Tennessee, United States
MD Anderson Cancer CenterHouston, Texas, United States
University of Utah - Huntsman Cancer Institute - PPDSSalt Lake City, Utah, United States
University of Virginia Comprehensive Cancer CenterCharlottesville, Virginia, United States
Fondazione IRCCS Istituto Nazionale dei TumoriMilan, Italy
Instituto Europeo di OncologiaMilan, Italy
Fondazione Policlinico Universitario A Gemelli-RomeRome, Italy
St Bartholomew's HospitalLondon, Middlesex, United Kingdom